{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:38:25Z","timestamp":1785537505568,"version":"3.56.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.4158\/ep-2017-0203","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T11:56:24Z","timestamp":1521633384000},"page":"329-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Estrogen Levels Do Not Rise With Testosterone Treatment For Transgender Men"],"prefix":"10.1016","volume":"24","author":[{"given":"Kelly J.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Weinand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Safer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2017-0203_bb0010","article-title":"How many adults identify as transgender in the United States?","author":"Flores","year":"2016","journal-title":"The Williams Inst"},{"key":"10.4158\/EP-2017-0203_bb0015","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"key":"10.4158\/EP-2017-0203_bb0020","author":"World Professional Association for Transgender Health","year":"2011","journal-title":"Standards of care for the health of transsexual, transgender, and gender nonconforming people, seventh version"},{"key":"10.4158\/EP-2017-0203_bb0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrendo.2014.139","article-title":"Gynaecomastia\u2014pathophysiology, diagnosis and treatment","volume":"10","author":"Narula","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP-2017-0203_bb0030","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0203_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1018638715498","article-title":"Endocrine therapy of transsexualism and potential complications of long-term treatment","volume":"27","author":"Futterweit","year":"1998","journal-title":"Arch Sex Behav"},{"key":"10.4158\/EP-2017-0203_bb0040","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/j.1743-6109.2009.01380.x","article-title":"Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals","volume":"6","author":"Perrone","year":"2009","journal-title":"J Sex Med"},{"key":"10.4158\/EP-2017-0203_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-14-0586","article-title":"Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI)","volume":"172","author":"Van Caenegem","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2017-0203_bb0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP-2017-0203_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/eje.0.1460505","article-title":"Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study","volume":"146","author":"Rolf","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2017-0203_bb0060","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1210\/jc.2002-020926","article-title":"Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism","volume":"87","author":"Ib\u00e1\u00f1ez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0203_bb0065","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1093\/humrep\/dei205","article-title":"Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls","volume":"20","author":"Villuendas","year":"2005","journal-title":"Hum Reprod"},{"key":"10.4158\/EP-2017-0203_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4158\/EP.14.2.248","article-title":"Out of the shadows: it is time to mainstream treatment for transgender patients","volume":"14","author":"Safer","year":"2008","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2017-0203_bb0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199808273390905","article-title":"Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency","volume":"339","author":"Bilezikian","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2017-0203_bb0080","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2005-1830","article-title":"Testosterone and estradiol among older men","volume":"91","author":"Orwoll","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2 Pt 1","key":"10.4158\/EP-2017-0203_bb0085","first-page":"E317","article-title":"Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals","volume":"276","author":"Elbers","year":"1999","journal-title":"Am J Physiol"},{"key":"10.4158\/EP-2017-0203_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"key":"10.4158\/EP-2017-0203_bb0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administered long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035607X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035607X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:05:05Z","timestamp":1761516305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2035607X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1530891X2035607X"],"URL":"https:\/\/doi.org\/10.4158\/ep-2017-0203","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen Levels Do Not Rise With Testosterone Treatment For Transgender Men","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2017-0203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}